Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort.
暂无分享,去创建一个
A. Cohen | A. Bitton | Y. Xiao | P. Lakatos | G. Wild | W. Afif | T. Bessissow | N. Hilzenrat | J. Wyse | A. Szilagyi | G. Friedman | P. Golovics | R. Kohen | A. Al Khoury | P. Galiatsatos | A. Cohen